• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

MMA Payout

The Business of Combat Sports

  • Home
  • MMA
    • UFC
    • Bellator
    • One
    • PFL
  • Boxing
  • Legal
  • Ratings
  • Payouts
  • Attendance
  • Gate

USADA issues 2 year ban for UFC light heavyweight

July 9, 2019 by Jason Cruz Leave a Comment

Former UFC light heavyweight Ivan Shtyrkov has accepted a two-year suspension from USADA for violation of the UFC anti-doping rules.  The Russian stated on social media that he tested positive for a banned substance and this was confirmed by USADA on Tuesday.

Despite accepting the suspension, Shtyrkov has signed with Rizin FF.

Shtyrkov accepted a fight against Devin Clark at UFC on ESPN +7 this past March but that fight was scrapped after USADA notified the UFC that two out-of-competition urine samples had returned an “atypical” result.  The samples contained the banned steroid boldenone and its metabolite 5β-androst-1-en-17β-ol-3-one.  Boldenone is a veterinarian drug used on horses but has been used by professional athletes.  Notably, Stephan Bonnar and Josh Barnett had tested positive for the banned substance.

Boldenone is a non-Specified Substance in the class of Anabolic Agents and prohibited at all times under the UFC Anti-Doping Policy, which has adopted the World Anti-Doping Agency (WADA) Prohibited List.

Shtyrkov is undefeated with 16 wins and one draw.  It was initially announced that he was “sick” and hospitalized as a reason from pulling out of his fight with Devin Clark.   Shtyrkov’s manager indicated that a USADA test came back with an abnormal reading and not a positive test for PEDs.

Payout Perspective: 

 Here’s a case where you can argue that the USADA tests were not conclusive for the banned substance.  Yet, evidence was clear enough to pull him from his UFC debut and we are brought back to the argument about how long a substance can remain in one’s system.  We’ve seen this with Jon Jones and this may have been another case.  Despite the ban, Shtyrkov has decided to continue his career with Rizin.

Filed Under: Drug Testing, Flagged by USADA, UFC, USADA

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

Featured

Muhammad Ali American Boxing Revival Act of 2026 introduced into Senate with minor changes

Plaintiffs file Answering Brief in Cirkunov Antitrust Appeal

Jai Opetaia files a lawsuit against IBF

Parties in Mayweather-CSI Entertainment lawsuit provide joint letter to court

Plaintiffs highlight outstanding discovery in Johnson antitrust case

UFC 329 Payout Perspective

Archives

MMA Payout Follow

MMAPayout

Were all four satisfied in the Senate version? #TKO #AliAct #Zuffa #ZuffaBoxing #Boxing

Ariel Helwani @arielhelwani

Nico Ali Walsh breaks down the four major changes he wants included in the revised Zuffa Boxing Revival Act:

"In layman's terms, financial transparency is absolutely essential—UBO disclosures, fighter pay. You've got to be able to show what money is being made.

Free agency.

Retweet on Twitter MMA Payout Retweeted

Re: Haney/Davis

The WBO congratulates Top Rank, Inc. on securing the promotional rights for the WBO Welterweight Championship contest between Devin Haney and Keyshawn Davis with a winning purse bid of $8,550,000.

Purse Distribution:
• Devin Haney: $6,412,500 (75%)
• Keyshawn

Retweet on Twitter MMA Payout Retweeted

@MMAPayout “Sad to see once great publication like NYT become yellow pages.”

A little too on the nose while tweeting from the official Ring account

The Trumpification of the press

Retweet on Twitter MMA Payout Retweeted

This is a totally normal thing for a boxing outlet to post.

Load More

Copyright © 2026 · MMA Payout: The Business of Combat Sports